![Anne Chun Longo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anne Chun Longo
Amministratore Delegato presso PharmatrophiX, Inc.
Profilo
Anne Chun Longo is currently the Chief Executive Officer at PharmatrophiX, Inc. She started this position in 2006.
She completed her undergraduate degree at Stanford University.
Posizioni attive di Anne Chun Longo
Società | Posizione | Inizio |
---|---|---|
PharmatrophiX, Inc.
![]() PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Amministratore Delegato | 01/01/2006 |
Formazione di Anne Chun Longo
Stanford University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
PharmatrophiX, Inc.
![]() PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Health Technology |
- Borsa valori
- Insiders
- Anne Chun Longo